HEADER VRAL PROTEIN/IMMUNE SYSTEM 17-FEB-22 7U0D TITLE LOCAL REFINEMENT OF CRYO-EM STRUCTURE OF THE INTERFACE OF THE OMICRON TITLE 2 RBD IN COMPLEX WITH ANTIBODIES B-182.1 AND A19-46.1 CAVEAT 7U0D RESIDUES ILE O 51 AND VAL O 52 THAT ARE NEXT TO EACH OTHER CAVEAT 2 7U0D IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE CAVEAT 3 7U0D BETWEEN C AND N IS 3.55. RESIDUES GLU O 81 AND LEU O 82 CAVEAT 4 7U0D THAT ARE NEXT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT CAVEAT 5 7U0D PROPERLY LINKED: DISTANCE BETWEEN C AND N IS 8.72. RESIDUES CAVEAT 6 7U0D LEU O 82 AND SER O 82A THAT ARE NEXT TO EACH OTHER IN THE CAVEAT 7 7U0D SAMPLE SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C CAVEAT 8 7U0D AND N IS 7.86. RESIDUES TYR O 176 AND SER O 177 THAT ARE CAVEAT 9 7U0D NEXT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 10 7U0D LINKED: DISTANCE BETWEEN C AND N IS 1.62. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SURFACE GLYCOPROTEIN; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEAVY CHAIN OF SARS-COV-2 ANTIBODY A19-46.1; COMPND 7 CHAIN: M; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: LIGHT CHAIN OF SARS-COV-2 ANTIBODY A19-46.1; COMPND 11 CHAIN: N; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: HEAVY CHAIN OF SARS-COV-2 ANTIBODY B1-182.1; COMPND 15 CHAIN: O; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: LIGHT CHAIN OF SARS-COV-2 ANTIBODY B1-182.1; COMPND 19 CHAIN: P; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL: HEK293F; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM_CELL: HEK293F; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 19 EXPRESSION_SYSTEM_CELL: HEK 293F; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 25 EXPRESSION_SYSTEM_CELL: HEK293F; SOURCE 26 MOL_ID: 5; SOURCE 27 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 28 ORGANISM_TAXID: 9606; SOURCE 29 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ANTIBODY, SARS-COV-2, OMICRON, B.1.1.529, RECEPTOR BINDING DOMAIN, KEYWDS 2 IMMUNE SYSTEM, VRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR T.ZHOU,P.D.KWONG REVDAT 3 16-OCT-24 7U0D 1 REMARK REVDAT 2 19-OCT-22 7U0D 1 JRNL REVDAT 1 30-MAR-22 7U0D 0 JRNL AUTH T.ZHOU,L.WANG,J.MISASI,A.PEGU,Y.ZHANG,D.R.HARRIS,A.S.OLIA, JRNL AUTH 2 C.A.TALANA,E.S.YANG,M.CHEN,M.CHOE,W.SHI,I.T.TENG,A.CREANGA, JRNL AUTH 3 C.JENKINS,K.LEUNG,T.LIU,E.D.STANCOFSKI,T.STEPHENS,B.ZHANG, JRNL AUTH 4 Y.TSYBOVSKY,B.S.GRAHAM,J.R.MASCOLA,N.J.SULLIVAN,P.D.KWONG JRNL TITL STRUCTURAL BASIS FOR POTENT ANTIBODY NEUTRALIZATION OF JRNL TITL 2 SARS-COV-2 VARIANTS INCLUDING B.1.1.529. JRNL REF SCIENCE V. 376 N8897 2022 JRNL REFN ESSN 1095-9203 JRNL PMID 35324257 JRNL DOI 10.1126/SCIENCE.ABN8897 REMARK 2 REMARK 2 RESOLUTION. 4.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.800 REMARK 3 NUMBER OF PARTICLES : 46244 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7U0D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1000263262. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TERNARY COMPLEX OF SARS-COV-2 REMARK 245 OMICRON RBD IN COMPLEX WITH REMARK 245 ANTIBODIES B1-182.1 AND A19-46.1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOT FOR 2-3.5 SECONDS BEFORE REMARK 245 PLUGGING. REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : 105000 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, M, N, O, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN O 1 REMARK 465 SER O 128 REMARK 465 LYS O 129 REMARK 465 SER O 130 REMARK 465 THR O 131 REMARK 465 SER O 132 REMARK 465 GLY O 133 REMARK 465 GLY O 134 REMARK 465 LYS O 214 REMARK 465 SER O 215 REMARK 465 CYS O 216 REMARK 465 ASP O 217 REMARK 465 LYS O 218 REMARK 465 GLU P 213 REMARK 465 CYS P 214 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER O 113 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CZ TYR O 145 N SER O 177 1.88 REMARK 500 CE2 TYR O 145 N SER O 177 1.89 REMARK 500 CE1 TYR O 145 N SER O 177 1.98 REMARK 500 CD2 TYR O 145 N SER O 177 2.07 REMARK 500 OG SER P 12 NH1 ARG P 107 2.09 REMARK 500 OH TYR O 145 O VAL O 169 2.14 REMARK 500 O SER O 32 N VAL O 52 2.15 REMARK 500 CD1 TYR O 145 N SER O 177 2.15 REMARK 500 O GLN N 40 OG SER N 86 2.16 REMARK 500 O ASP M 114 OG1 THR N 48 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR O 145 CG TYR O 145 CD2 0.432 REMARK 500 TYR O 145 CG TYR O 145 CD1 0.467 REMARK 500 TYR O 145 CD1 TYR O 145 CE1 0.888 REMARK 500 TYR O 145 CE1 TYR O 145 CZ 0.542 REMARK 500 TYR O 145 CZ TYR O 145 CE2 0.559 REMARK 500 TYR O 145 CE2 TYR O 145 CD2 0.903 REMARK 500 TYR O 176 C SER O 177 N 0.284 REMARK 500 SER O 177 N SER O 177 CA 0.186 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO M 198 CA - N - CD ANGL. DEV. = -13.6 DEGREES REMARK 500 SER O 177 C - N - CA ANGL. DEV. = 30.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 352 161.99 62.75 REMARK 500 CYS B 391 43.40 -140.68 REMARK 500 ASP B 428 54.81 -93.29 REMARK 500 CYS B 432 -174.64 -171.35 REMARK 500 LYS B 458 53.81 -93.05 REMARK 500 ASN B 477 -99.99 57.36 REMARK 500 ASN B 487 -6.21 72.01 REMARK 500 LEU B 492 -73.86 116.91 REMARK 500 ARG B 493 71.19 58.17 REMARK 500 GLU B 516 -166.93 -79.92 REMARK 500 LEU B 518 -7.00 77.51 REMARK 500 HIS B 519 -1.86 61.28 REMARK 500 VAL B 524 -62.32 -102.75 REMARK 500 CYS B 525 -168.36 54.86 REMARK 500 PRO M 107 170.11 -59.31 REMARK 500 TYR M 109 62.28 39.64 REMARK 500 MET M 113 136.28 55.07 REMARK 500 PHE N 34 74.05 58.46 REMARK 500 LEU N 49 -60.60 -102.23 REMARK 500 THR N 53 -9.93 72.00 REMARK 500 PRO N 145 -167.07 -79.54 REMARK 500 THR O 16 -60.79 -107.22 REMARK 500 SER O 17 -173.07 -172.43 REMARK 500 SER O 32 -167.76 -161.92 REMARK 500 SER O 54 142.92 -172.08 REMARK 500 ARG O 66 19.95 50.57 REMARK 500 TYR O 91 178.85 64.17 REMARK 500 SER O 112 -164.10 -162.81 REMARK 500 PRO O 147 -1.20 -58.17 REMARK 500 ALA O 158 -159.48 -150.39 REMARK 500 LEU O 159 64.45 64.28 REMARK 500 THR O 160 37.66 -97.92 REMARK 500 SER O 161 39.34 -98.05 REMARK 500 GLN O 192 145.62 69.11 REMARK 500 ASN O 204 97.05 -68.07 REMARK 500 ALA P 84 -168.48 -165.12 REMARK 500 GLU P 105 -166.68 -162.74 REMARK 500 PHE P 116 163.41 179.73 REMARK 500 TYR P 186 17.05 56.86 REMARK 500 SER P 202 -136.13 62.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7TCC RELATED DB: PDB REMARK 900 THE COMPLEX THAT CONTAINS THIS LOCAL REFINEMENT REMARK 900 RELATED ID: EMD-26256 RELATED DB: EMDB REMARK 900 LOCAL REFINEMENT OF CRYO-EM STRUCTURE OF THE INTERFACE OF THE REMARK 900 OMICRON RBD IN COMPLEX WITH ANTIBODIES B-182.1 AND A19-46.1 DBREF1 7U0D B 331 526 UNP A0A7U3CI26_SARS2 DBREF2 7U0D B A0A7U3CI26 8 203 DBREF 7U0D M 1 231 PDB 7U0D 7U0D 1 231 DBREF 7U0D N 1 216 PDB 7U0D 7U0D 1 216 DBREF 7U0D O 1 218 PDB 7U0D 7U0D 1 218 DBREF 7U0D P 1 214 PDB 7U0D 7U0D 1 214 SEQADV 7U0D ASP B 339 UNP A0A7U3CI2 GLY 16 VARIANT SEQADV 7U0D LEU B 371 UNP A0A7U3CI2 SER 48 VARIANT SEQADV 7U0D PRO B 373 UNP A0A7U3CI2 SER 50 VARIANT SEQADV 7U0D PHE B 375 UNP A0A7U3CI2 SER 52 VARIANT SEQADV 7U0D LYS B 440 UNP A0A7U3CI2 ASN 117 VARIANT SEQADV 7U0D SER B 446 UNP A0A7U3CI2 GLY 123 VARIANT SEQADV 7U0D ASN B 477 UNP A0A7U3CI2 SER 154 VARIANT SEQADV 7U0D LYS B 478 UNP A0A7U3CI2 THR 155 VARIANT SEQADV 7U0D ALA B 484 UNP A0A7U3CI2 LYS 161 VARIANT SEQADV 7U0D ARG B 493 UNP A0A7U3CI2 GLN 170 VARIANT SEQADV 7U0D SER B 496 UNP A0A7U3CI2 GLY 173 VARIANT SEQADV 7U0D ARG B 498 UNP A0A7U3CI2 GLN 175 VARIANT SEQADV 7U0D HIS B 505 UNP A0A7U3CI2 TYR 182 VARIANT SEQRES 1 B 196 ASN ILE THR ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN SEQRES 2 B 196 ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS SEQRES 3 B 196 ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR SEQRES 4 B 196 ASN LEU ALA PRO PHE PHE THR PHE LYS CYS TYR GLY VAL SEQRES 5 B 196 SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL SEQRES 6 B 196 TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG SEQRES 7 B 196 GLN ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR SEQRES 8 B 196 ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE SEQRES 9 B 196 ALA TRP ASN SER ASN LYS LEU ASP SER LYS VAL SER GLY SEQRES 10 B 196 ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN SEQRES 11 B 196 LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR SEQRES 12 B 196 GLN ALA GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY PHE SEQRES 13 B 196 ASN CYS TYR PHE PRO LEU ARG SER TYR SER PHE ARG PRO SEQRES 14 B 196 THR TYR GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL SEQRES 15 B 196 LEU SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS SEQRES 16 B 196 GLY SEQRES 1 M 231 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 M 231 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 M 231 PHE THR LEU SER SER TYR GLY MET HIS TRP VAL ARG GLN SEQRES 4 M 231 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL ILE SER SEQRES 5 M 231 TYR ASP GLY SER ASN LYS TYR TYR VAL ASP SER VAL LYS SEQRES 6 M 231 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 M 231 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 M 231 ALA VAL TYR TYR CYS ALA ARG GLY TRP ALA TYR TRP GLU SEQRES 9 M 231 LEU LEU PRO ASP TYR TYR TYR GLY MET ASP VAL TRP GLY SEQRES 10 M 231 GLN GLY THR THR VAL THR VAL SER SER ALA SER THR LYS SEQRES 11 M 231 GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SER SEQRES 12 M 231 THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS SEQRES 13 M 231 ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER SEQRES 14 M 231 GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL SEQRES 15 M 231 LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL VAL SEQRES 16 M 231 THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR ILE SEQRES 17 M 231 CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP SEQRES 18 M 231 LYS LYS VAL GLU PRO LYS SER CYS ASP LYS SEQRES 1 N 216 GLN THR VAL VAL THR GLN GLU PRO SER PHE SER VAL SER SEQRES 2 N 216 PRO GLY GLY THR VAL THR LEU THR CYS GLY LEU SER SER SEQRES 3 N 216 GLY SER VAL SER THR ALA TYR PHE PRO SER TRP TYR GLN SEQRES 4 N 216 GLN THR PRO GLY GLN ALA PRO ARG THR LEU ILE TYR GLY SEQRES 5 N 216 THR ASN THR ARG SER SER GLY VAL PRO ASP ARG PHE SER SEQRES 6 N 216 GLY SER ILE LEU GLY ASN LYS ALA ALA LEU THR ILE THR SEQRES 7 N 216 GLY ALA GLN ALA ASP ASP GLU SER ASP TYR TYR CYS VAL SEQRES 8 N 216 LEU TYR MET GLY ARG GLY ILE VAL VAL PHE GLY GLY GLY SEQRES 9 N 216 THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 N 216 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 N 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 N 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 N 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 N 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 N 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 N 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 N 216 THR VAL ALA PRO THR GLU CYS SER SEQRES 1 O 228 GLN MET GLN LEU VAL GLN SER GLY PRO GLU VAL LYS LYS SEQRES 2 O 228 PRO GLY THR SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 O 228 PHE THR PHE THR SER SER ALA VAL GLN TRP VAL ARG GLN SEQRES 4 O 228 ALA ARG GLY GLN ARG LEU GLU TRP ILE GLY TRP ILE VAL SEQRES 5 O 228 VAL GLY SER GLY ASN THR ASN TYR ALA GLN LYS PHE GLN SEQRES 6 O 228 GLU ARG VAL THR ILE THR ARG ASP MET SER THR SER THR SEQRES 7 O 228 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 O 228 ALA VAL TYR TYR CYS ALA ALA PRO TYR CYS SER GLY GLY SEQRES 9 O 228 SER CYS PHE ASP GLY PHE ASP ILE TRP GLY GLN GLY THR SEQRES 10 O 228 MET VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 O 228 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 O 228 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 O 228 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 O 228 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 O 228 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 O 228 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 O 228 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 O 228 GLU PRO LYS SER CYS ASP LYS SEQRES 1 P 215 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 P 215 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 P 215 GLN SER VAL SER SER SER TYR LEU ALA TRP TYR GLN GLN SEQRES 4 P 215 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 P 215 SER SER ARG ALA THR GLY PHE PRO ASP ARG PHE SER GLY SEQRES 6 P 215 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 P 215 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 P 215 TYR GLY ASN SER PRO TRP THR PHE GLY GLN GLY THR LYS SEQRES 9 P 215 VAL GLU ILE ARG ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 P 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 P 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 P 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 P 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 P 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 P 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 P 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 P 215 SER PHE ASN ARG GLY GLU CYS HET NAG B 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG C8 H15 N O6 HELIX 1 AA1 PHE B 338 ASN B 343 1 6 HELIX 2 AA2 ASP B 364 ASN B 370 5 7 HELIX 3 AA3 GLY B 404 ARG B 408 5 5 HELIX 4 AA4 GLY B 416 ASN B 422 1 7 HELIX 5 AA5 SER B 438 SER B 443 1 6 HELIX 6 AA6 GLY B 502 GLN B 506 5 5 HELIX 7 AA7 THR M 28 TYR M 32 5 5 HELIX 8 AA8 ASP M 62 LYS M 65 5 4 HELIX 9 AA9 ARG M 87 THR M 91 5 5 HELIX 10 AB1 SER M 140 THR M 144 5 5 HELIX 11 AB2 SER M 200 LEU M 202 5 3 HELIX 12 AB3 SER N 30 PHE N 34 5 5 HELIX 13 AB4 GLN N 81 GLU N 85 5 5 HELIX 14 AB5 SER N 125 ALA N 131 1 7 HELIX 15 AB6 THR N 185 HIS N 192 1 8 HELIX 16 AB7 ALA N 211 SER N 216 5 6 HELIX 17 AB8 MET O 73 THR O 75 5 3 HELIX 18 AB9 SER P 121 LYS P 126 5 6 SHEET 1 AA1 5 LYS B 356 ILE B 358 0 SHEET 2 AA1 5 VAL B 395 ILE B 402 -1 O ALA B 397 N LYS B 356 SHEET 3 AA1 5 TYR B 508 PHE B 515 -1 O SER B 514 N TYR B 396 SHEET 4 AA1 5 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 5 AA1 5 PHE B 375 TYR B 380 -1 N TYR B 380 O GLY B 431 SHEET 1 AA2 4 GLN M 3 SER M 7 0 SHEET 2 AA2 4 SER M 17 SER M 25 -1 O SER M 21 N SER M 7 SHEET 3 AA2 4 THR M 78 ASN M 84 -1 O MET M 83 N LEU M 18 SHEET 4 AA2 4 PHE M 68 ASP M 73 -1 N ASP M 73 O THR M 78 SHEET 1 AA3 6 GLY M 10 VAL M 12 0 SHEET 2 AA3 6 THR M 120 VAL M 124 1 O THR M 123 N GLY M 10 SHEET 3 AA3 6 ALA M 92 ARG M 98 -1 N TYR M 94 O THR M 120 SHEET 4 AA3 6 MET M 34 GLN M 39 -1 N GLN M 39 O VAL M 93 SHEET 5 AA3 6 LEU M 45 ILE M 51 -1 O ALA M 49 N TRP M 36 SHEET 6 AA3 6 LYS M 58 TYR M 60 -1 O TYR M 59 N VAL M 50 SHEET 1 AA4 4 GLY M 10 VAL M 12 0 SHEET 2 AA4 4 THR M 120 VAL M 124 1 O THR M 123 N GLY M 10 SHEET 3 AA4 4 ALA M 92 ARG M 98 -1 N TYR M 94 O THR M 120 SHEET 4 AA4 4 VAL M 115 TRP M 116 -1 O VAL M 115 N ARG M 98 SHEET 1 AA5 4 SER M 133 LEU M 137 0 SHEET 2 AA5 4 THR M 148 TYR M 158 -1 O GLY M 152 N LEU M 137 SHEET 3 AA5 4 TYR M 189 PRO M 198 -1 O VAL M 197 N ALA M 149 SHEET 4 AA5 4 VAL M 176 THR M 178 -1 N HIS M 177 O VAL M 194 SHEET 1 AA6 4 SER M 133 LEU M 137 0 SHEET 2 AA6 4 THR M 148 TYR M 158 -1 O GLY M 152 N LEU M 137 SHEET 3 AA6 4 TYR M 189 PRO M 198 -1 O VAL M 197 N ALA M 149 SHEET 4 AA6 4 VAL M 182 LEU M 183 -1 N VAL M 182 O SER M 190 SHEET 1 AA7 3 THR M 164 TRP M 167 0 SHEET 2 AA7 3 TYR M 207 HIS M 213 -1 O ASN M 212 N THR M 164 SHEET 3 AA7 3 THR M 218 VAL M 224 -1 O VAL M 224 N TYR M 207 SHEET 1 AA8 4 VAL N 4 GLN N 6 0 SHEET 2 AA8 4 THR N 17 LEU N 24 -1 O GLY N 23 N THR N 5 SHEET 3 AA8 4 LYS N 72 THR N 78 -1 O ILE N 77 N VAL N 18 SHEET 4 AA8 4 PHE N 64 LEU N 69 -1 N LEU N 69 O LYS N 72 SHEET 1 AA9 6 SER N 9 VAL N 12 0 SHEET 2 AA9 6 THR N 105 VAL N 109 1 O THR N 108 N PHE N 10 SHEET 3 AA9 6 SER N 86 MET N 94 -1 N SER N 86 O LEU N 107 SHEET 4 AA9 6 SER N 36 GLN N 40 -1 N TYR N 38 O TYR N 89 SHEET 5 AA9 6 ARG N 47 TYR N 51 -1 O ILE N 50 N TRP N 37 SHEET 6 AA9 6 THR N 55 ARG N 56 -1 O THR N 55 N TYR N 51 SHEET 1 AB1 4 SER N 9 VAL N 12 0 SHEET 2 AB1 4 THR N 105 VAL N 109 1 O THR N 108 N PHE N 10 SHEET 3 AB1 4 SER N 86 MET N 94 -1 N SER N 86 O LEU N 107 SHEET 4 AB1 4 ILE N 98 PHE N 101 -1 O ILE N 98 N MET N 94 SHEET 1 AB2 4 SER N 118 PHE N 122 0 SHEET 2 AB2 4 ALA N 134 PHE N 143 -1 O LEU N 139 N THR N 120 SHEET 3 AB2 4 TYR N 176 LEU N 184 -1 O ALA N 178 N ILE N 140 SHEET 4 AB2 4 VAL N 163 THR N 165 -1 N GLU N 164 O TYR N 181 SHEET 1 AB3 4 SER N 118 PHE N 122 0 SHEET 2 AB3 4 ALA N 134 PHE N 143 -1 O LEU N 139 N THR N 120 SHEET 3 AB3 4 TYR N 176 LEU N 184 -1 O ALA N 178 N ILE N 140 SHEET 4 AB3 4 SER N 169 LYS N 170 -1 N SER N 169 O ALA N 177 SHEET 1 AB4 4 SER N 157 PRO N 158 0 SHEET 2 AB4 4 THR N 149 ALA N 154 -1 N ALA N 154 O SER N 157 SHEET 3 AB4 4 TYR N 195 HIS N 201 -1 O GLN N 198 N ALA N 151 SHEET 4 AB4 4 SER N 204 VAL N 210 -1 O LYS N 208 N CYS N 197 SHEET 1 AB5 4 GLN O 3 GLN O 6 0 SHEET 2 AB5 4 VAL O 20 SER O 25 -1 O LYS O 23 N VAL O 5 SHEET 3 AB5 4 THR O 77 GLU O 81 -1 O MET O 80 N VAL O 20 SHEET 4 AB5 4 THR O 68 THR O 70 -1 N THR O 70 O TYR O 79 SHEET 1 AB6 2 GLU O 10 VAL O 11 0 SHEET 2 AB6 2 VAL O 109 THR O 110 1 O THR O 110 N GLU O 10 SHEET 1 AB7 2 VAL O 34 GLN O 39 0 SHEET 2 AB7 2 LEU O 45 ILE O 51 -1 O GLY O 49 N TRP O 36 SHEET 1 AB8 2 ALA O 93 ALA O 94 0 SHEET 2 AB8 2 ILE O 102 TRP O 103 -1 O ILE O 102 N ALA O 94 SHEET 1 AB9 3 SER O 120 LEU O 124 0 SHEET 2 AB9 3 ALA O 137 LYS O 143 -1 O LEU O 141 N PHE O 122 SHEET 3 AB9 3 LEU O 178 THR O 183 -1 O VAL O 182 N LEU O 138 SHEET 1 AC1 3 THR O 151 VAL O 152 0 SHEET 2 AC1 3 VAL O 198 HIS O 200 -1 O ASN O 199 N THR O 151 SHEET 3 AC1 3 THR O 205 VAL O 207 -1 O VAL O 207 N VAL O 198 SHEET 1 AC2 2 THR P 10 SER P 12 0 SHEET 2 AC2 2 LYS P 103 GLU P 105 1 O LYS P 103 N LEU P 11 SHEET 1 AC3 2 ARG P 18 ARG P 24 0 SHEET 2 AC3 2 ASP P 70 SER P 76 -1 O PHE P 71 N CYS P 23 SHEET 1 AC4 4 SER P 53 ARG P 54 0 SHEET 2 AC4 4 ARG P 45 TYR P 49 -1 N TYR P 49 O SER P 53 SHEET 3 AC4 4 LEU P 33 GLN P 38 -1 N GLN P 37 O ARG P 45 SHEET 4 AC4 4 VAL P 85 GLN P 90 -1 O TYR P 87 N TYR P 36 SHEET 1 AC5 3 SER P 131 LEU P 135 0 SHEET 2 AC5 3 LEU P 175 THR P 180 -1 O SER P 177 N CYS P 134 SHEET 3 AC5 3 GLN P 160 VAL P 163 -1 N GLN P 160 O THR P 178 SHEET 1 AC6 2 VAL P 146 TRP P 148 0 SHEET 2 AC6 2 CYS P 194 VAL P 196 -1 O GLU P 195 N GLN P 147 SSBOND 1 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 2 CYS B 379 CYS B 432 1555 1555 2.04 SSBOND 3 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 4 CYS B 480 CYS B 488 1555 1555 2.04 SSBOND 5 CYS M 153 CYS M 209 1555 1555 2.03 SSBOND 6 CYS N 22 CYS N 90 1555 1555 2.03 SSBOND 7 CYS N 138 CYS N 197 1555 1555 2.04 SSBOND 8 CYS O 22 CYS O 92 1555 1555 2.03 SSBOND 9 CYS O 97 CYS O 100B 1555 1555 2.03 SSBOND 10 CYS O 140 CYS O 196 1555 1555 2.03 SSBOND 11 CYS P 23 CYS P 88 1555 1555 2.03 SSBOND 12 CYS P 134 CYS P 194 1555 1555 2.03 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.44 CISPEP 1 PHE M 159 PRO M 160 0 -4.28 CISPEP 2 GLU M 161 PRO M 162 0 2.14 CISPEP 3 TYR N 144 PRO N 145 0 3.16 CISPEP 4 SER P 94 PRO P 95 0 0.21 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000